ccdd_code,ccdd_formal_name,ccdd_type,policy_type,policy_reference,special_groupings_status,special_groupings_status_effective_time,changes
"02453908","TEVA-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919","ccdd_formal_name: ""ACT BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) TEVA CANADA LIMITED"" -> TEVA-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) TEVA CANADA LIMITED"
"02453916","TEVA-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919","ccdd_formal_name: ""ACT BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) TEVA CANADA LIMITED"" -> TEVA-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) TEVA CANADA LIMITED"
"02230369","CLONAPAM (clonazepam 2 mg oral tablet) BAUSCH HEALTH, CANADA INC.","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919","ccdd_formal_name: ""CLONAPAM (clonazepam 2 mg oral tablet) VALEANT CANADA LP/VALEANT CANADA S.E.C."" -> CLONAPAM (clonazepam 2 mg oral tablet) BAUSCH HEALTH, CANADA INC."
"02230366","CLONAPAM (clonazepam 0.5 mg oral tablet) BAUSCH HEALTH, CANADA INC.","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919","ccdd_formal_name: ""CLONAPAM (clonazepam 0.5 mg oral tablet) VALEANT CANADA LP/VALEANT CANADA S.E.C."" -> CLONAPAM (clonazepam 0.5 mg oral tablet) BAUSCH HEALTH, CANADA INC."
"02453916","TEVA-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919","ccdd_formal_name: ""ACT BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) TEVA CANADA LIMITED"" -> TEVA-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) TEVA CANADA LIMITED"
"02230368","CLONAPAM (clonazepam 1 mg oral tablet) BAUSCH HEALTH, CANADA INC.","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919","ccdd_formal_name: ""CLONAPAM (clonazepam 1 mg oral tablet) VALEANT CANADA LP/VALEANT CANADA S.E.C."" -> CLONAPAM (clonazepam 1 mg oral tablet) BAUSCH HEALTH, CANADA INC."
"02453908","TEVA-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919","ccdd_formal_name: ""ACT BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) TEVA CANADA LIMITED"" -> TEVA-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) TEVA CANADA LIMITED"
